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Abstract
Background: In Pseudomonas fluorescens ST, the promoter of the styrene catabolic operon, PstyA,
is induced by styrene and is subject to catabolite repression. PstyA regulation relies on the StyS/
StyR two-component system and on the IHF global regulator. The phosphorylated response
regulator StyR (StyR-P) activates PstyA in inducing conditions when it binds to the high-affinity site
STY2, located about -40 bp from the transcription start point. A cis-acting element upstream of
STY2, named URE, contains a low-affinity StyR-P binding site (STY1), overlapping the IHF binding
site. Deletion of the URE led to a decrease of promoter activity in inducing conditions and to a
partial release of catabolite repression. This study was undertaken to assess the relative role played
by IHF and StyR-P on the URE, and to clarify if PstyA catabolite repression could rely on the
interplay of these regulators.
Results: StyR-P and IHF compete for binding to the URE region. PstyA full activity in inducing
conditions is achieved when StyR-P and IHF bind to site STY2 and to the URE, respectively. Under
catabolite repression conditions, StyR-P binds the STY1 site, replacing IHF at the URE region. StyR-
P bound to both STY1 and STY2 sites oligomerizes, likely promoting the formation of a DNA loop
that closes the promoter in a repressed conformation. We found that StyR and IHF protein levels
did not change in catabolite repression conditions, implying that PstyA repression is achieved
through an increase in the StyR-P/StyR ratio.
Conclusion: We propose a model according to which the activity of the PstyA promoter is
determined by conformational changes. An open conformation is operative in inducing conditions
when StyR-P is bound to STY2 site and IHF to the URE. Under catabolite repression conditions
StyR-P cellular levels would increase, displacing IHF from the URE and closing the promoter in a
repressed conformation. The balance between the open and the closed promoter conformation
would determine a fine modulation of the promoter activity. Since StyR and IHF protein levels do
not vary in the different conditions, the key-factor regulating PstyA catabolite repression is likely
the kinase activity of the StyR-cognate sensor protein StyS.
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Background
Styrene is a basic building block for the manufacture of a
broad range of products containing molecules such as
polystyrene, butadiene-styrene latex, styrene copolymers
and unsaturated polyester resins. These products range
from packaging materials to food service items to a myr-
iad of consumer electronics, construction, transportation
and medical applications. Styrene exposure may cause
contact-based skin inflammation, irritation of eyes, nose
and respiratory tract, while neurological effects, such as
alterations in vision, hearing loss and longer reaction
times, have been associated with styrene exposure in the
workplace [1]. Microbial biodegradation and polluted air
biofiltration are attractive options for the removal of sty-
rene from the environment, because they are cost-effective
and do not generate secondary contaminants. Therefore
styrene-degrading microorganisms have been receiving
increasing interest, mainly concerning the factors that can
help or impair the degradation process [2].
Despite the large number of bacteria isolated for their
capability to grow on styrene, genetic studies have essen-
tially been performed on strains belonging to the genus
Pseudomonas [2]. In these strains styrene degradation starts
with the oxidation of the vinyl double bond to styrene
oxide by styrene monooxygenase (SMO), a two-compo-
nent flavin-dependent oxygenase encoded by the styA and
styB genes, whose reaction mechanism has been proposed
[3,4]. styC codes for styrene oxide isomerase (SOI), which
converts styrene oxide to phenylacetaldehyde that is in
turn oxidized to phenylacetic acid by phenylacetaldehyde
dehydrogenase (PADH), encoded by styD [5-10]. The styE
gene codes for a protein likely involved in the active trans-
port of styrene [11]. These genes form an operon, named
styABCDE, that is highly conserved in all the styrene-
degrading Pseudomonas strains studied up to now (Figure
1A) [12]. Phenylacetic acid is a common substrate for
Pseudomonas spp., probably because, beside styrene, deg-
radation of many other aromatic compounds converge
towards the formation of this compound [13].
In Pseudomonas fluorescens ST, as well as in the other sty-
rene-degrading Pseudomonas strains, the expression of the
styABCDE operon is regulated by the StyS/StyR two-com-
The styrene-catabolic system of P. fluorescens ST Figure 1
The styrene-catabolic system of P. fluorescens ST. (A) Organization of the stySR regulatory and of the styABCDE catabolic 
operons in Pseudomonas spp. styS, sensor histidine kinase; styR, response regulator; styA and styB, styrene monooxygenase 
(SMO); styC, styrene oxide isomerase (SOI); styD, phenylacetaldehyde dehydrogenase (PADH); styE, styrene transport protein. 
PstyS and PstyA are the promoters of the regulatory and catabolic operons, respectively. (B) Schematic representation of the 
PstyA promoter region. Inverted red arrows, StyR-P-binding sites STY1, STY2 and STY3 (numbering refers to distance from 
PstyA transcription start site). Blue box, IHF-binding site. Bent arrow, transcription start site.BMC Microbiology 2008, 8:92 http://www.biomedcentral.com/1471-2180/8/92
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ponent system, encoded by the stySR operon (Figure 1A)
[9,10]. The product of the styS gene, StyS, is a protein of
about 109 kDa, predicted to be a hybrid histidine kinase
(HK) with several distinct functional domains. A distinc-
tive feature of this protein with respect to other hybrid
HKs is the presence of two different kinase cores (HK/
ATPase domains). Moreover it contains an internal
receiver domain and two putative input domains, consist-
ing of the PAS and PAC sensory sub-domains [12]. The
styR gene encodes a protein, StyR, of about 23 kDa disclos-
ing the typical structural features of other response regula-
tors [14]. Activation of StyR requires phosphorylation that
triggers StyR dimerization and DNA binding [15].
Three distinct binding sites, endowed with different affin-
ities for phosphorylated StyR (StyR-P), have been charac-
terized on PstyA, the promoter of the styrene catabolic
operon (Figure 1B) [16]. Site STY2 is the highest-affinity
StyR-P binding site. The DNA region upstream of STY2,
named URE (Upstream Regulatory Element), contains a
lower affinity StyR-P binding site (STY1) overlapping a
binding site for the Integration Host Factor (IHF) global
regulator, placed in the opposite helix with respect to
STY1 site. However, when a promoter fragment contain-
ing both STY1 and STY2 was used in DNase I protection
experiments, we found that StyR-P bound these sites
simultaneously, indicating that StyR-P binding to these
sites is cooperative. The lowest affinity StyR-P binding site
(STY3) is located downstream of the transcription start
point [16].
PstyA activity is induced by styrene and partially repressed
by the addition of glucose (60% repression) or of other
more favourable carbon sources [17]. This phenomenon,
named carbon catabolite repression, is frequently
observed in the regulation of aromatic catabolic pathways
in pseudomonads, although, in most cases, little is known
about the mediators or the mechanisms underlying
repression. In their whole, the studies carried out up to
date rule out in Pseudomonas the involvement of cyclic
AMP and indicates that different genes are involved in the
catabolite repression of different catabolic pathways
[reviewed in [18,19]].
Studies on the activity of deleted and/or mutated variants
of PstyA, in cells grown in inducing (growth on styrene as
sole carbon source) or catabolite repression (glucose
added to a styrene growing culture) conditions, showed
that StyR-P acts as an activator when it binds to site STY2,
and that this binding is essential for promoter activity
[20]. Conversely, deletion of the URE decreased PstyA
activity and partially relieved it from glucose-mediated
repression. When in this deleted promoter the STY3 site
was also inactivated, glucose-mediated repression was
completely abolished. From these data we concluded that
StyR-P acts as a repressor when it binds to site STY3, and
that the URE region of PstyA is involved in both styrene-
dependent induction and catabolite repression [16].
However, the relative role played by IHF and StyR-P on
this cis-acting element remained unclear.
This study was undertaken to address this issue and to
understand if changes in the relative levels of StyR-P and
IHF could determine PstyA catabolite repression.
The results obtained make it possible to propose a model
according to which the fine regulation of the PstyA pro-
moter, in the different growth conditions, mainly
depends on the phosphorylation levels of StyR, thus on
the activity of the cognate StyS sensor kinase.
Results and discussion
StyR-P and IHF compete for binding to the URE region
The promoter region of the styABCDE operon is shown in
Figure 1B. The PstyA region located upstream of the STY2
site, referred to as URE (Upstream Regulatory Element),
contains two cis-acting regulatory elements: an IHF bind-
ing site and the StyR-P binding site STY1 [16]. Since the
STY1 and IHF binding sites overlap, it was postulated that
StyR-P and IHF could compete for binding to the URE
region. To clarify this issue, competition experiments were
performed by DNase I protection assays on a DNA-probe
encompassing site STY2 and the URE region of PstyA.
As shown in Figure 2, the IHF protection pattern (nucle-
otides -110/-75 from the PstyA transcription start site; Fig-
ure 2, lanes 7 and 15) is wider than the StyR-P protection
pattern on STY1 (nucleotides -110/-90 from the transcrip-
tion start site; Figure 2, lanes 1 and 9), so that they are eas-
ily distinguishable. The addition of increasing StyR-P
concentrations (Figure 2, lanes 6 to 2) to the IHF/probe
preformed complex, led to the protection of site STY2, and
to the replacement of the IHF protection pattern with the
narrower StyR-P protection pattern on the URE region. In
Figure 2 triangles indicate the bands that are distinctive of
the pattern obtained in the absence of IHF. Three of these
bands become hypersensitive sites under increasing con-
centrations of StyR-P (indicated by open triangles in Fig-
ure 2), suggesting a conformational change of PstyA
structure (see below). Likewise, the addition of increasing
IHF concentrations (Figure 2, lanes 10 to 14) to the StyR-
P/probe preformed complex, led to the replacement of the
StyR-P protection pattern at the STY1 site with the wider
IHF protection pattern. In this case the binding of IHF to
the URE region did not affect the binding of StyR-P to site
STY2.
In the whole, these data demonstrate that IHF and StyR-P
are in binding competition for the URE region, and thatBMC Microbiology 2008, 8:92 http://www.biomedcentral.com/1471-2180/8/92
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IHF can bind the URE region without altering StyR-P
binding to site STY2.
StyR-P and IHF play opposite roles when bound to the 
URE region
In a previous work we showed that deletion of the URE
led to a decreased promoter activity in inducing condi-
tions (growth on styrene as sole carbon source) and to a
partial desensitization to carbon catabolite repression
(growth on styrene plus glucose). Actually, PstyA activity
was 60% reduced in catabolite repression, while it was
only 38% reduced in the URE-deleted variant of the pro-
moter in the same growth conditions [16]. To better
understand the contribution of StyR-P and IHF in deter-
mining the PstyA activity under styrene induction and glu-
cose catabolite repression, we generated two variants of
this promoter: Pa1STY1mut and Pa1IHFmut, each con-
taining nucleotide substitutions such that impair StyR-P
binding to site STY1 or IHF binding to the URE, respec-
tively (Figure 3A). Electrophoretic mobility shift assays
and DNase I protection assays were carried out to confirm
that a DNA probe encompassing the URE region and car-
rying mutations inactivating STY1 (indicated with aster-
isks in Figure 3A) was able to form a complex with IHF,
but not with StyR-P. As well, a DNA probe encompassing
the URE and carrying mutations in the IHF binding site
(indicated with triangles in Figure 3A) was able to form a
complex with StyR-P, but not with IHF (data not shown).
Pa1STY1mut and Pa1IHFmut were cloned in the pro-
moter-probe vector pPR9TT, in frame with the reporter
gene  lacZ, generating pPR9STY1mut and pPR9IHFmut
(Table 1; Figure 3A), respectively, and introduced in P. flu-
orescens ST. We assayed the activity of these promoters
with respect to that of the wild-type promoter Pa1, moni-
toring β-galactosidase levels in inducing, repressing, and
non-inducing conditions. Briefly, ST(pPR9Pa1),
ST(pPR9STY1mut) and ST(pPR9IHFmut) strains pre-
grown on styrene, were diluted and subcultured in the
same medium for two hours, and then divided into three
flasks containing styrene (inducing condition), styrene
plus glucose (repressing condition), and glucose alone
(non-inducing condition) [16,17]. The β-galactosidase
levels disclosed by the different constructs along the
growth in the different culture conditions are shown in
Figure 3B. The styrene pre-induced strains with the differ-
ent constructs diluted the accumulated β-galactosidase at
the same rate during the growth on glucose, a condition
in which the PstyA promoter is not induced. This result
made it possible to consider the β-galactosidase activity
values obtained in this culture condition, for each strain
and for each point of the growth curve, as 100% of repres-
sion of the PstyA promoter. Similarly, we assumed the β-
galactosidase values observed along the exponential
growth on styrene (inducing condition) as 100% of the
Characterization of StyR-P and IHF binding to the URE Figure 2
Characterization of StyR-P and IHF binding to the 
URE. DNase I protection assay in which a DNA fragment 
extending from -145 to -8 (Top Strand) of the PstyA pro-
moter was incubated with different amounts of IHF and/or 
StyR-P proteins prior to DNase I digestion. Numbering 
refers to PstyA transcription start site. Solid brackets indicate 
the regions showing specific protection by StyR-P; dashed 
bracket indicates the region showing specific protection by 
IHF. Triangles indicate bands that are distinctive of the pro-
tection pattern obtained in the absence of IHF (open trian-
gles indicate hypersensitive sites). M, Maxam and Gilbert 
sequencing reactions (A+G); IHF concentrations: lanes 1, 8, 
and 9, no IHF added; lanes 2 to 7, 4.0 μM; lanes 10 to 15, 0.5 
μM, 1.0 μM, 2.0 μM, 4.0 μM, 8.0 μM and 8.0 μM, respec-
tively. StyR-P concentrations: lanes 7, 8, and 15, no StyR-P 
added; lanes 1 to 6, 8.0 μM, 8.0 μM, 4.0 μM, 2.0 μM, 1.0 μM 
and 0.5 μM, respectively; lanes 9 to 14, 4.0 μM.BMC Microbiology 2008, 8:92 http://www.biomedcentral.com/1471-2180/8/92
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PstyA activity. Since the differences in promoter activity
among the different strains kept constant during the
growth curve, in Figure 3C a comparison of promoter
activity after two exponential cell divisions, in the differ-
ent culture conditions, is reported.
As shown in Figures 3B and 3C, mutation of the STY1 site
in pPR9STY1mut produced no effect on the promoter
activity under inducing conditions with respect to
pPR9Pa1. Thus, this StyR-P-binding site is not involved in
promoter activation. On the contrary, in the contempo-
rary presence of styrene and glucose (repressing condi-
tions), the same mutation caused a significant relief of
repression (from 60% repression disclosed by the wild-
type promoter Pa1  to 30% repression) indicating that
StyR-P bound to site STY1 plays a role in PstyA catabolite
repression. We previously demonstrated that also site
STY3 is responsible for a reduction of catabolite repres-
sion from 60% to 26% [16], so it seems that these low-
affinity StyR-P binding sites are both involved in PstyA
repression.
As far as IHF is concerned, we observed no β-galactosidase
activity in pPR9IHFmut in all the tested culture condi-
tions. This was an unexpected result, since in a previous
work we found that the deletion of the URE region led
only to a 33% reduction of promoter activity in inducing
condition with respect to pPR9Pa1 [16]. A possible inter-
pretation of this finding is suggested by the fact that, in
spite of the different affinity of StyR-P for the single STY
sites, in the absence of IHF it binds STY1 and STY2 sites
simultaneously [16]. This cooperative binding suggested
that two dimers of StyR-P bound to sites STY1 and STY2
could interact, bending DNA and forming a repressive
loop. An indication that major changes in the three-
dimensional structure of the promoter only occur when
StyR-P is bound to STY1 and STY2 is the concomitant
appearance of DNase I hypersensitive sites between these
two sites (Figure 2, lane 1). These DNase I hypersensitive
sites are not detectable when IHF displaces StyR-P from
site STY1 and only STY2 is bound by StyR-P (Figure 2, lane
14). The formation of a StyR-P tetramer and DNA loop-
ing, probably favored by the presence of an intrinsically
curved sequence between STY1 and STY2 [20], would
impair RNA polymerase access to the promoter.
StyR-P binding to sites STY1 and STY2 promotes protein 
tetramerization
In order to corroborate the hypothesis that the occupancy
of both STY1 and STY2 sites by StyR-P induces the gener-
ation of a repressive DNA loop, we performed experi-
ments aimed to assess if StyR-P dimers can form
tetramers, and if this oligomerization is stimulated by the
presence of a DNA fragment containing the StyR-P bind-
ing sites STY1 and STY2.
Functional role of the URE region Figure 3
Functional role of the URE region. (A) Schematic repre-
sentation of PstyA and its mutated derivatives cloned in the 
promoter probe vector pPR9TT. Plasmid designations are 
given on the left. Red inverted arrows indicate the StyR-P 
binding sites. The IHF binding site is blue-boxed. Nucleotides 
numbering is referred to the PstyA transcription start site. 
The white rectangle indicates the styA ORF. The grey arrow 
indicates the lacZ gene fused to styA. A detail of the URE 
region is reported on the top. Asterisks and triangles indicate 
nucleotides mutated (A→T and T→A substitutions) to gen-
erate the pPR9STY1mut and pPR9IHFmut constructs, 
respectively. (B) β-galactosidase activities disclosed by P. fluo-
rescens ST strains carrying the different pPR9TT-derivative 
plasmids represented in (A). Filled symbols, pPR9Pa1; open 
symbols, pPR9STY1mut; diamonds, cultures growing on sty-
rene; circles, styrene-grown precultures to which both sty-
rene and 0.4% glucose were added at time zero; triangles, 
styrene-grown precultures to which only 0.4% glucose was 
added at time zero. (C) β-galactosidase activities measured 
after two exponential cell divisions on styrene (white bars), 
on styrene plus 0.4% (wt/vol) glucose (grey bars), or on 0.4% 
(wt/vol) glucose (black bars), are reported in the histogram. 
The extent of glucose mediated repression in carbon catabo-
lite repression condition is indicated by the double arrow 
line. Repression was calculated by assuming that the pro-
moter activity in styrene was 100% and the promoter activity 
in glucose corresponded to 100% repression. Standard devia-
tions (vertical lines) are based on the mean values of five 
independent experiments.BMC Microbiology 2008, 8:92 http://www.biomedcentral.com/1471-2180/8/92
Page 6 of 13
(page number not for citation purposes)
To determine the oligomerization state of StyR-P, the StyR
protein was phosphorylated with acetylphosphate, and
afterwards treated with the disuccinimidyl suberate (DSS)
cross-linking agent, in absence or in the presence of
increasing amounts of a DNA fragment encompassing the
STY1 and STY2 sites. As shown in Figure 4A, StyR-P can
form dimers of the predicted size of about 50 kDa and
higher order multimers. The size of the higher-order mul-
timers of about 75 kDa and 110 kDa could be consistent
with the formation of trimers and tetramers, respectively.
However, native PAGE analysis performed on the acetyl-
phosphate-treated sample showed that more than 99% of
StyR was in the dimeric form, prior to the addition of DSS
(data not shown) [12]. After cross-linking and denaturing
SDS-PAGE analysis, more than 50% of the protein
migrated as the monomeric form. This indicates that the
extent of protein-protein cross-linking was far from com-
plete, under these experimental conditions. Thus, it is
likely that the band of about 75 kDa derives from incom-
plete cross-linking of a tetramer rather than from the for-
mation of a trimer.
The results of the cross-linking experiment highlight that
StyR-P dimers are actually able to interact, forming a
tetramer, also in the absence of DNA. Tetramers forma-
tion is significantly enhanced by addition of a DNA frag-
ment encompassing sites STY1 and STY2 (Figure 4A), but
not by the addition of non-specific DNA (Figure 4B). This
specific DNA-mediated oligomerization is a strong indica-
tion that two StyR-P dimers bound on sites STY1 and STY2
form a StyR-P tetramer, likely inducing the formation of a
DNA loop. Occurrence of changes in the promoter confor-
mation when StyR-P is bound to both STY1 and STY2 is
also indicated by the appearance of hypersensitive bands
between these sites in DNase I protection experiments
(Figure 2). Moreover, a strong evidence of the formation
of a "closed" promoter conformation that would impair
RNA polymerase (RNAP) access to the promoter is the
absence of PstyA activity in pPR9IHFmut. Taken together
the above evidence concur to strengthen the significance
of the cross-linking results.
IHF has a positive role on PstyA activity by itself
The above reported molecular and physiological results
concur with the view that the cooperative binding of StyR-
P to STY1 and STY2 is likely counteracted in vivo by IHF
which, competing with StyR-P for binding to the URE
region, would act as a positive modulator of promoter
activity. However, in a previous work we found that dele-
tion of the entire URE led to a 33% decrease in promoter
activity in inducing conditions (growth on styrene as sole
carbon source) with respect to the full length promoter
[16]. From this result we argued that IHF could not merely
have the role of displacing StyR-P from the repressive site
STY1, since in this case no difference in promoter activity
would have been found between the full length and the
URE-deleted promoters. To clarify this issue, we compared
the activity of pPR9Pa1 and pPR9IHFmut in the heterolo-
gous host E. coli. As a control we also tested the β-galactos-
idase activity of pPR9STY1mut (Figure 5). In this system
there was no StyR-P dependent activation of PstyA, but the
promoter had a basal level activity anyway. This basal
level activity was the same in pPR9Pa1 and in
pPR9STY1mut, while it strongly decreased in
pPR9IHFmut. This result demonstrates that IHF, beside
displacing StyR-P from the STY1 repressive site, has also a
positive effect on PstyA transcription by itself.
The molecular mechanism of action of IHF on the PstyA
promoter remains an open issue. In many cases IHF bind-
Table 1: Bacterial strains and plasmids used in this study.
Strains and Plasmids Relevant characteristics and plasmids contruction or source Reference
Strains
P. fluorescens ST Sty+ [39]
E. coli DH5α endA1 hsdR17 supE44 thi-1 recA1 gyrA96 (NalR) relA1Δ (lacIZYA-argF)U169 deoR(Φ80dlacZΔM15) Bethesda Res. Lab.
Plasmids
pBluescript II KS+ Cloning vector; ApR; 2.9 Kb. Stratagene
pPR9TT lacZ promoter probe vector; ApR; CmR. [40]
pTE50 pTZ19R derivative containing a P. fluorescens ST chromosomal fragment carrying the genes coding 
for styR, styA and styB; ApR.
[7]
pRK2013 Helper plasmid; ColE1 replicon; Mob+; Tra+; KmR. [37]
pSTY1/2 155 bp fragment, encompassing nucleotides -145 to -8, with respect to the styA transcription start 
point ligated to the EcoRI-PstI sites of pBluescript II KS+; ApR.
[16]
pPR9Pa1 355 bp fragment, encompassing nucleotides -115 to +240, with respect to the styA transcription 
start point, ligated to the XhoI-BamHI sites of pPR9TT; ApR; CmR.
[20]
pPR9STY1mut Same construct as pPR9Pa1, but the cloned sequence carries a double mutation in positions -97 and 
-96 from the styA trascription start point; ApR; CmR.
This study
pPR9IHFmut Same construct as pPR9Pa1, but the cloned sequence carries a double mutation in positions -101 
and -91 from the styA trascription start point; ApR; CmR.
This studyBMC Microbiology 2008, 8:92 http://www.biomedcentral.com/1471-2180/8/92
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ing induces DNA-looping facilitating the interaction of an
upstream regulatory element with RNAP [21]. However,
our data rule out this possibility, since the IHF binding
site is located at the very 5'- end of the minimum PstyA
fragment endowed with full activity [20]. Therefore, it is
likely that IHF acts as an activator through a different
mechanism. For instance, it has been reported that IHF
can activate transcription, without contacting RNAP, by
facilitating duplex destabilization in the -10 region
[22,23].
PstyA catabolite repression does not rely on variation in 
StyR and IHF protein levels
Although the role of IHF in Pseudomonas physiology is far
from understood, it has been often involved in the regula-
tion of toxic compound degradation [18]. The above data
show that binding of IHF to the URE exerts a positive
effect on PstyA activity, under inducing conditions, while
binding of StyR-P on the same region is involved in cat-
abolite repression. Since StyR-P and IHF are in binding
competition for the URE region, it is reasonable to sup-
pose that, starting from an inducing condition (growth on
styrene as sole carbon source), the glucose-mediated
repression (growth on styrene and glucose) of PstyA could
DNA-mediated StyR-P tetramerization Figure 4
DNA-mediated StyR-P tetramerization. Western blot analysis of StyR-P (100 nM) incubated with increasing amounts of 
the DNA fragment STY1/STY2 (panel A) or poly d(I)-d(C) (panel B), and afterwards treated with the cross-linking agent DSS. 
Brackets indicate the 110 kDa band corresponding to StyR-P tetrameric form, and the 75 kDa band derived from incomplete 
cross-linking of tetramers (see text for details). Dimeric (50 kDa) and monomeric (25 kDa) StyR-P forms are indicated. The 
concentrations of DNA in each sample were: lane 1, no DNA added; lanes 2 to 5, 50, 100, 200, 400 nM, respectively.BMC Microbiology 2008, 8:92 http://www.biomedcentral.com/1471-2180/8/92
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be due to an increase in StyR-P and/or to a decrease in IHF
cellular levels.
To test this hypothesis, we monitored the levels of StyR
and IHF proteins by western analysis after the addition of
glucose to a styrene growing culture.
As previously described, P. fluorescens ST carrying
pPR9Pa1 plasmid was cultured with styrene as sole carbon
source, then the culture was diluted, subcultured in the
same medium for two hours, and divided into two flasks
containing styrene, or styrene plus glucose. β-galactosi-
dase levels were measured every 1.5 hours and protein
samples for western analysis were withdrawn, in parallel,
up to 7.5 hours after division. In inducing condition, StyR
and IHF levels did not vary along the growth curve (data
not shown), in accordance with PstyA steady levels (Figure
6A). Surprisingly, IHF levels did not vary and StyR levels
did not increase, even when glucose was added to the sty-
rene growing culture (Figure 6B), although PstyA activity
decreased in this culture condition (Figure 6A).
This finding strongly suggests that in repressing condi-
tions the low-affinity site STY1 is occupied as a conse-
quence of an increase in the levels of phosphorylated
StyR, and not for an increase in StyR or for a decrease in
IHF absolute protein levels.
Conclusion
In our previous studies we showed that StyR dimerizes
upon phosphorylation and that StyR-P dimers are able to
bind PstyA  on three distinct cis-acting elements (STY1,
STY2 and STY3) with different affinity [15,16]. Functional
studies showed that the high-affinity binding site STY2 is
essential for promoter activation, while the low-affinity
site STY3 is in part responsible for catabolite repression of
the promoter. The URE region, encompassing the StyR-P
binding site STY1 and the IHF binding site, is involved in
both styrene-induction and catabolite repression of PstyA
[16].
In this study we unravel the role of the URE region in
PstyA  regulation, showing that the mutually exclusive
binding of StyR-P and IHF to this cis-acting element causes
opposite effects on PstyA activity. Moreover, we demon-
strate that the levels of IHF and StyR do not change in the
different growth conditions, making the phosphorylation
degree of StyR the main factor in the regulation of styrene
catabolism genes expression.
On the whole, our research allows us to propose a model
for PstyA regulation according to which the PstyA activity
is determined by changes of its structure. An open confor-
mation is operative in inducing conditions when StyR-P is
Analysis of StyR and IHF protein levels Figure 6
Analysis of StyR and IHF protein levels. (A) β-galactosi-
dase assays performed with P. fluorescens ST strains carrying 
the pPR9Pa1 plasmid (Table 1), grown in styrene (filled cir-
cles) and styrene plus 0.4% (wt/vol) glucose (open circles), 
along the growth curve. (B) Western hybridization per-
formed with anti-StyR and anti-IHF antibodies on the cellular 
soluble fractions derived from the styrene plus glucose cul-
ture. Sampling times are indicated above the bands, and cor-
respond to the sampling times of the β-galactosidase assays 
shown in (A); lane C, control with purified StyR and IHF pro-
teins.
Role of IHF on PstyA activity Figure 5
Role of IHF on PstyA activity. β-galactosidase activities 
disclosed by E. coli strains carrying the pPR9TT-derivative 
plasmids indicated below the histogram. The β-galactosidase 
assays were carried out on cells grown in LB medium at 
37°C to an A600 ≅ 2.0. Standard deviations (vertical lines) are 
based on the mean values of five independent experiments.BMC Microbiology 2008, 8:92 http://www.biomedcentral.com/1471-2180/8/92
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bound to STY2 site and IHF to the URE. Under catabolite
repression conditions StyR-P cellular levels would
increase, displacing IHF from the URE and resulting in the
achievement of a promoter closed conformation. Also the
occupation of STY3 site would take part to the closed pro-
moter conformation, since we had previously demon-
strated that its inactivation partially relieved PstyA from
glucose repression (Figure 7) [16]. The balance between
the open and the closed promoter conformations would
determine a fine modulation of PstyA activity.
In this perspective the key-factor regulating carbon cat-
abolite repression would be the activity of the StyR-cog-
nate sensor protein StyS. Our data converge to the notion
that the activity of the sensor kinase StyS is enhanced
when, besides styrene, cells are in a condition that deter-
mines a high redox potential (such as growth on styrene
plus glucose). This view is consistent with the presence of
two PAS domains and two kinase domains in the StyS sen-
sor, which is a strong indication that two different signals
can be sensed by this protein. If the two signals are styrene
and the cell redox potential, a signal often perceived by
PAS domains, their integration could modulate the kinase
activity of the sensor, leading to an increase in the levels
of phosphorylated StyR, under carbon catabolite repres-
sion conditions, and consequently to PstyA down-regula-
tion [24].
Concerning the physiological role of IHF, in E. coli this
protein regulates more than 100 genes and in Pseudomonas
it is involved in the regulation of several processes, espe-
cially in toxic compound degradation [18,25]. Previous
studies showed that in E. coli and Pseudomonas IHF levels
increase upon entry into stationary phase in LB growing
cultures and suggested a role for IHF in stress response
[26,27]. It is likely that in P. fluorescens ST we did not
observe the same phenomenon because we used minimal
medium or because styrene is a stress factor by itself.
The TodS/T regulatory system of toluene catabolism in P.
putida strain DOT-T1E strongly resembles the StyS/R sys-
tem. The TodT response regulator binds with different
affinity three sites of the promoter PtodX and IHF is essen-
tial for activating transcription [28,29]. However, in this
system all these TodT binding sites have a positive effect
on promoter activation and the role of IHF is to bend
DNA, hence favouring the contact between the TodT acti-
vator bound further upstream and the α-subunit of RNA
polymerase. Accordingly, the position of TodT and IHF
binding sites on PtodX promoter is very different from that
of StyR and IHF binding sites on PstyA. The divergent evo-
lution of StyS/R-PstyA and TodS/T-PtodX probably reflects
the need for integrating these peripheral pathways into
the global regulatory circuits of the corresponding differ-
ent strains.
In Pseudomonas the majority of the catabolic routes for
toxic compounds are regulated by a specific regulator
responding to the actual substrate and by one or more glo-
bal regulators devoted to couple the activity of the cata-
bolic operon promoter to cell metabolism [18,19,30].
With this respect, the styrene-catabolism regulatory sys-
tem is peculiar because a unique regulatory device (the
Proposed model for the regulation of PstyA Figure 7
Proposed model for the regulation of PstyA. (A) When 
growing on styrene as sole carbon source, the StyS kinase 
activity leads to levels of StyR-P such that this protein binds 
only to the high-affinity actvating-site STY2, while IHF binds 
to the URE region. This "open" conformation would allow 
the binding of the RNA polymerase (RNAP) to PstyA, pro-
moting transcription. (B) In carbon catabolite repression 
conditions (growth on styrene plus glucose) the increased 
StyS kinase activity would lead to higher levels of StyR-P, so 
that this protein can bind also to the low-affinity repressive-
sites STY1 and STY3, displacing IHF from the URE region. 
This "closed" promoter conformation would impair the bind-
ing of the RNAP to the promoter. The balance between 
open and closed promoter conformations would determine a 
fine modulation of the promoter activity.BMC Microbiology 2008, 8:92 http://www.biomedcentral.com/1471-2180/8/92
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StyS/StyR two component system) integrates the response
to the specific stimulus (styrene) with the utilization of a
higher-energy carbon source.
The fine modulation exerted by the interplay of StyR-P
and IHF on PstyA activity, although complex, could not be
the only regulatory device controlling styrene catabolism
in P. fluorescens ST. It was recently reported that in Pseu-
domonas sp. Y2, in which the sty regulatory and catabolic
genes are highly homologous to those of strain ST, the
repressor PaaX represses PstyA in the absence of pheny-
lacetyl-CoA, the first intermediate metabolite of the sty-
rene degradation lower-pathway [31]. The authors
suggested that PaaX could have a role in coordinating the
expression of the upper and lower styrene catabolic path-
ways to avoid the accumulation of toxic catabolic inter-
mediates such as styrene oxide and phenylacetaldehyde.
We believe that both StyR-P and PaaX repressive mecha-
nisms can be operative also in ST strain, probably acting
in different metabolic conditions.
In the experimental design here reported we found that
when styrene-induced cells are transferred to a medium
containing both styrene and glucose, both carbon sources
are simultaneously utilized (since PstyA activity is dimin-
ished, but not abrogated). Conversely, when non-induced
cells are transferred to a medium containing both glucose
and styrene, they exhibit a typical diauxic growth, in
which glucose is utilized first [17]. Therefore it seems that
catabolite repression could be achieved through different
mechanisms, depending on the metabolic status of the
cells preceding the addition of the alternative carbon
source. It could be that when styrene is added to a glucose
growing culture, the available energy is invested in adap-
tation to the high-toxic styrene, prior to metabolizing it.
Conversely, when cells are already adapted to styrene and
are productively using it as carbon source, there is not
much advantage to completely repress styrene degrada-
tion in favor of glucose utilization, and the two carbon
sources are thus exploited in parallel. The simultaneous
utilization of an high-energy carbon source and of an aro-
matic compound has also been reported by J.L. Ramos
and co-workers, who demonstrated that in P. putida
KT2440 (pWWO) cells utilize glucose and toluene simul-
taneously [32].
In addition to its relevance in understanding the physio-
logical mechanisms underlying aromatic compound
catabolism, this study could lay the basis for the genera-
tion of engineered strains desensitized to carbon catabo-
lite repression, thus improved in styrene catabolic
potential.
Methods
Bacterial strains, plasmids, media and chemicals
The bacterial strains and plasmids used in this study are
listed in Table 1. P. fluorescens ST and E. coli cells were rou-
tinely grown at 30°C and 37°C, respectively, in Luria-Ber-
tani (LB) medium or mineral salts medium supplemented
with styrene, or 0.4% (wt/vol) glucose, or both [33,34].
Styrene was added via the gas phase as previously
described [7]. When necessary, cultures were supple-
mented with ampicillin (Ap, 100 μg/ml), kanamycin
(Km, 50 μg/ml) or chloramphenicol (Cm, 30 μg/ml for E.
coli; 200 μg/ml for P. fluorescens ST).
Recombinant DNA techniques
Details on the construction of plasmids are described in
Table 1. Preparation of plasmid DNA, purification of
DNA fragments, restrictions, ligations and transforma-
tions of E. coli, were carried out by standard procedures
[15,33]. PCR amplifications were performed using Pfu
polymerase (Stratagene) and the pTE50 plasmid as DNA
template (Table 1) [7]. The sequences of oligonucleotides
used in this study are shown in Table 2. Automated
sequences were performed by MWG Biotech sequence
services (MWG Biotech).
Table 2: Oligonucleotides used in this study.
Name Sequence (5'-3')a Positionb Sitec
P1/FW GCTCTAGAGGTGTAGTAAATATAAGT -115 XbaI
P169/FW GCTCTAGAGGTGTAGTAAATATTAGT -115 XbaI
P87/FW TAAATATAAGTAAATGATTTTTAAT -108 -
P89/FW TAAATATTAGTTTATGAATTTTAAT -108 -
P86/RV ATTAAAAATCATTTACTTATATTTA -84 -
P88/RV ATTAAAATTCATAAACTAATATTTA -84 -
P17/RV GGGGTACCTACGTAGTAGTAGTGG +274 KpnI
P35/FW GGGAATTCCGTTGACTGCTTCGGG -145 EcoRI
P56/RV AAACTGCAGAGCTAACACCAGCAGC -8 PstI
a introduced restriction sites are underlined; the nucleotides in bold-face and underlined correspond to the A → T and T → A introduced 
substitutions with respect to the styA wild-type sequence.
b distance in bp from PstyA transcription start point [10].
c restriction recognition sites.BMC Microbiology 2008, 8:92 http://www.biomedcentral.com/1471-2180/8/92
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DNase I protection assay
The DNase I protection assay was performed as previously
described [16]. In brief, the probe derived from EcoRI/SacI
digestion of the pSTY1/2 plasmid (Table 1) and encom-
passing nucleotides -145/-8 with respect to PstyA  tran-
scription start point was labelled by fill-in with [α-32P]
dATP [16]. The labelled probe (0.5 nM concentration)
was mixed with different amounts of phosphorylated StyR
(StyR-P) (0.5 to 8.0 μM, as indicated in legend of Figure
2) and/or IHF (0.5 to 8.0 μM, as indicated in legend of
Figure 2) in "Phosphorylation Buffer" (43 mM Tris-ace-
tate pH 8.0, 30 mM potassium acetate, 8 mM MgCl2, 27
mM ammonium acetate, 1 mM DTT, 80 mM KCl, 10%
(vol/vol) glycerol, 4% (wt/vol) polyethylene glycol, 100
μg/ml bovine serum albumin) containing 0.1 μg/μl
poly(dI-dC) and 2 mM CaCl2. In vitro phosphorylation of
StyR was previously described [15]. DNA-protein com-
plexes were allowed to form at 30°C for 15 min in a total
volume of 50 μl for reaction. After 1 min at 25°C, DNase
I (0.4 u; Roche Biochemicals) was added to the reaction
mixtures. The reaction mixture was incubated for 1 min at
25°C and then stopped by the addition of 150 μl of "Stop
Solution" (0.2 M sodium acetate pH 7.0, 0.1 M ethylene-
diaminetetraacetic acid pH 8.0, 0.15% (wt/vol) sodium
dodecyl sulfate, 100 μg/ml tRNA). DNA from the foot-
printing mixture was phenol-chloroform extracted, etha-
nol-precipitated and dissolved in 5 μl of "Sequence
Loading Buffer" [33]. After 3 min denaturation at 95°C,
DNA was loaded on a 7% DNA sequencing gel [33]. The
A+G Maxam and Gilbert reaction was carried out with the
same probe and loaded on the gel along with the foot-
printing samples [33].
Construction of PstyA::lacZ fusions and β-galactosidase 
assays
The construction of pPR9TT-derivatives pPR9Pa1 has
been previously described [20]. For the construction of
plasmids pPR9STY1mut and pPR9IHFmut, a site-directed
mutagenesis of PstyA was performed by the "Splicing by
Overlap Extension PCR" method using the primers
described in Table 2, as previously described [35,36].
These oligonucleotides are mutually complementary and
correspond to a DNA region located from nt -108 to -84
with respect to the styA transcription start point. The A →
T and T → A introduced substitutions, with respect to the
wild-type sequence, are indicated in Table 2. In the first
step, two distinct PCR reactions (PCR-1 and PCR-2) were
carried out using chromosomal plasmid pTE50 (Table 1)
as template to introduce the mutation in the PCR prod-
ucts. In the PCR-1 Pa1STY1mut was amplified with prim-
ers P1/FW and P86/RV, while Pa1IHFmut with primers
P169/FW and P88/RV. In the PCR-2 reactions, the reverse
primer was P17/RV, while the forward primer was P87/
FW for Pa1STY1mut and P89/FW for Pa1IHFmut. In the
second PCR step the products from PCR-1 and PCR-2
were used as both primers and templates. In this step a
total DNA amount (PCR-1 + PCR-2) of 125 ng has been
used in a 100 μl reaction. After the first 5 cycles (94°C, 1
min; 68°C, 1 min; 72°C, 1 min), the reverse primer P17/
RV and either primer: P1/FW or P169/FW, were added
and the reaction was continued for 25 cycles.
The different PCR products were first blunt-cloned in Hin-
cII-digested pBluescriptII KS+ (Stratagene) and checked by
sequencing. Afterwards, the fragments cloned in the right
orientation were excised by XhoI-BamHI digestion and
ligated to compatible sites of the promoter probe vector
pPR9TT (Table 1) in frame with the lacZ reporter gene. All
pPR9TT-derivatives were transferred from E. coli to P. flu-
orescens ST by triparental matings with the helper plasmid
pRK2013 (Table 1) [37].
In order to measure β-galactosidase activity, P. fluorescens
ST cells harboring pPR9TT-derived plasmids, were grown
for 12 h at 30°C in mineral salts medium (MM) supple-
mented with styrene as carbon source; cells were then
diluted to a cell density corresponding to A600 ≅ 0.05 in
the same medium and subcultured until cultures reached
A600 ≅ 0.2. Cultures were then divided into three flasks
and 0.4% (wt/vol) glucose was added to one flask. Sam-
ples were withdrawn, every 1.5 hours, during the entire
growth curve and β-galactosidase activity was measured as
described by Miller [38]. The β-galactosidase assays per-
formed in the E. coli strains carrying the different pPR9TT-
derivative plasmids were carried out on cells grown in LB
medium at 37°C to an A600 ≅ 2.0.
Protein-protein cross-linking assay
The DNA fragment STY1/STY2 (nucleotides -145 to -8
with respect to PstyA transcription start point) used to pro-
mote StyR-P tetramerization was obtained by PCR ampli-
fication with the primers P35/FW and P56/RV described
in Table 2. StyR-P (100 nM) was incubated with different
concentrations of the STY1/STY2 PCR product or in pres-
ence of poly d(I)-d(C) (from 50 to 400 nM) in "Binding
Buffer" (20 mM Tris-HCl, 2 mM EDTA, 5 mM MgCl2, 30
mM KCl, 5% (vol/vol) glycerol, 0.025% (vol/vol) Noni-
det P-40, and 30 μg/ml poly (dI-dC); pH 8.0). After 15
min of incubation at 30°C, disuccinimidyl suberate
(DSS) was added to a final concentration of 15 mM, fol-
lowed by incubation at room temperature for 60 min. To
stop the cross-linking reaction, 5 μl of "6X Protein Sample
Buffer" was added to the samples [33]. Cross-linking
products were separated by electrophoresis on a 10% (wt/
vol) sodium dodecyl sulfate-polyacrylamide gel [33]. Pro-
teins were electroblotted to nitrocellulose and StyR was
detected with murine anti-6xHis monoclonal antibodies
(Qiagen) and alkaline phosphatase-conjugate goat anti-
mouse secondary antibody [15].BMC Microbiology 2008, 8:92 http://www.biomedcentral.com/1471-2180/8/92
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Polyclonal antiserum production and Western analyses
Purified StyR (200 μg) was emulsioned with complete Fre-
und's adjuvant (Sigma) and used to immunize a mouse
by intramuscular injection. After 3 weeks, a second boost
of StyR (150 μg) in complete Freund's adjuvant (Sigma)
was given, followed by a third boost (100 μg) at the sixth
week. The animal was bled 2 weeks later and the serum
was stored at 4°C. Animal experiments were performed
according to the legislative decree 116/92 by the Italian
Ministry of Health. Western blotting and immunohybrid-
ization were carried out with anti-StyR antiserum
(1:1,500), anti-IHF antiserum (1:1,000) and alkaline
phosphatase-conjugate anti-mouse IgG as secondary anti-
body (1:5,000; Promega) [33]. Final development was
performed with the "BCIP/NBT Color Development Sub-
strate" (Promega), as recommended by the manifacturer.
Anti-IHF antiserum was a generous gift from Prof. S.D.
Goodman, University of Southern California, Los Ange-
les, CA, USA.
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